Corporate ActionJul 20, 2026, 07:36 AM
REGENXBIO Raises $107.8M in Public Offering of Stock & Warrants
AI Summary
REGENXBIO Inc. announced the pricing of an underwritten public offering, raising approximately $107.8 million in net proceeds. The offering comprised 10,003,889 shares of common stock at $9.00 per share and 1,111,111 pre-funded warrants at $8.9999 per warrant. The underwriters fully exercised their 30-day option to purchase an additional 1,667,250 shares of common stock. The offering is expected to close on July 20, 2026, subject to customary closing conditions.
Key Highlights
- REGENXBIO Inc. raised approximately $107.8 million in net proceeds from a public offering.
- The offering included 10,003,889 shares of common stock at $9.00 per share.
- It also included 1,111,111 pre-funded warrants at $8.9999 per warrant.
- Underwriters fully exercised their option to purchase an additional 1,667,250 shares of common stock.
- The offering is expected to close on July 20, 2026.
- Pre-funded warrants have an exercise price of $0.0001 per share and do not expire.
Price Impact
More from RGNX